Simphotek Inc

Simphotek Inc, based in Newark, NJ, specializes in advanced medical devices for treatment planning in photodynamic therapy (PDT), particularly for advanced cancers. Their flagship product, Dosie, is an integrated computational device that offers precise simulations of light distribution and drug toxicity, enabling oncologists and medical physicists to tailor treatment plans to individual patients.

Dosie employs sophisticated mathematical methods, including Monte Carlo and Finite Element techniques, to model various PDT doses and optimize treatment parameters. By incorporating all relevant variables, Simphotek's technology stands out as the first commercially available solution capable of accurately predicting PDT outcomes across different cancer types.

Generated from the website